GENE ONLINE|News &
Opinion
Blog

Ranking & Reports
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Analysis of the Patent Industry for Treating Erectile Dysfunction (ED)
2023-06-08
Investigate the Current Status of Rivaroxaban Generic Drug Application in China
2023-03-01
Patent Landscape Analysis of Gene Therapy
2023-02-08
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
Patent Landscape Analysis of Canine Vaccines
2023-01-04
GeneOnline’s Pick: Top 10 New FDA-approved Drugs in 2022
2022-12-30
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
GeneOnline’s Pick: Top 10 Industry News Stories in 2022
2022-12-26
A Force To Be Reckoned With – BioBetter Biologics
2022-12-14
2026: The Promise of Synthetic Biology
2022-08-11
Korean Companies Occupying South Korea’s Diverse Biotech Landscape
2022-08-03
South Korea’s Biotech Industry:Trends, Landscape, and Clusters Overview
2022-08-01
1 2 3
LATEST
Eli Lilly Breaks Records with $9B Total Investment in Indiana Weight-loss Drug Expansion
2024-05-27
New Regulatory Measures in China A First in the Fight Against Sedentary Behavior in Children
2024-05-24
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024
2024-05-23
AstraZeneca’s $1.5 Billion ADC Manufacturing Facility in Singapore
2024-05-23
Hims & Hers Health Inc. Tipping the Scales of the Weight Loss Market — and Wall Street is Loving it!
2024-05-22
GV Announces Cooperation with CICC
2024-05-22
Eli Lilly and Aktis Oncology Partner to Advance Novel Radiopharmaceuticals
2024-05-22
EVENT
Scroll to Top